Park Avenue Securities’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$900K Buy
16,542
+2,408
+17% +$117K 0.01% 1001
2026
Q1
$606K Buy
14,134
+5,478
+63% +$236K ﹤0.01% 1027
2025
Q4
$379K Sell
8,656
-3,981
-32% -$165K ﹤0.01% 1224
2025
Q3
$522K Buy
12,637
+3,825
+43% +$154K ﹤0.01% 1165
2025
Q2
$388K Buy
8,812
+1,454
+20% +$58.1K ﹤0.01% 1178
2025
Q1
$272K Buy
7,358
+707
+11% +$25.2K ﹤0.01% 1035
2024
Q4
$221K Buy
+6,651
New +$216K ﹤0.01% 1399
2023
Q1
Sell
-11,570
Closed -$186K 847
2022
Q4
$186K Sell
11,570
-1,128
-9% -$18.4K ﹤0.01% 1148
2022
Q3
$199K Sell
12,698
-2,984
-19% -$57.7K ﹤0.01% 1067
2022
Q2
$326K Buy
15,682
+2,557
+19% +$52.7K 0.01% 881
2022
Q1
$298K Buy
+13,125
New +$256K 0.01% 954

Other funds holding EXEL

Park Avenue Securities's EXEL Position: Q2 2026 in Review

Park Avenue Securities increased its Exelixis (EXEL) stake by 17% in Q2 2026, buying an estimated $117K and bringing the position to 16,542 shares worth $900K. The position accounts for 0.01% of the portfolio, ranked #1001.

Park Avenue Securities first reported a position in EXEL in Q1 2022 and has held it in 11 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Park Avenue Securities held 16,542 shares of Exelixis worth $900K as of Q2 2026.
  • Park Avenue Securities bought 2,408 Exelixis shares in Q2 2026, an estimated $117K.
  • Exelixis made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1001 holding.
  • Park Avenue Securities first reported a position in Exelixis in Q1 2022 and has held it in 11 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.